From a public health perspective, pharmacist oversight remains the most appropriate framework for nicotine pouch access. Pharmacists are healthcare professionals trained to support smoking cessation, monitor nicotine use, provide guidance on appropriate product selection, and help prevent unintended youth uptake or misuse. Expanding access beyond pharmacies would primarily serve commercial retail interests rather than advancing health outcomes or smoking cessation objectives. If nicotine pouches are to remain positioned as a healthcare-oriented nicotine replacement product, their distribution model should continue to reflect that purpose.
HRC believes nicotine products making smoking cessation and health-related claims should remain connected to healthcare settings where pharmacists can provide guidance, counselling, and support. Canada’s experience with vaping demonstrated how quickly alternative nicotine categories can outpace regulation when commercialization occurs faster than oversight and enforcement. The vaping sector has since become characterized by a fragmented and often disjointed policy framework, with overlapping federal and provincial regulations creating significant enforcement challenges, market inconsistencies, and ongoing public policy concerns. Many of those same warning signs are now emerging within the nicotine pouch category. Maintaining pharmacy-only access provides a significantly clearer and more coherent regulatory framework that better aligns product access with public health objectives, professional oversight, and responsible nicotine management.
OUR RESEARCH
Examining Patient Outcomes
HRC is actively engaged in nicotine policy and healthcare advocacy with a focus on smoking cessation, youth protection, public safety, and enforcement. Our work examines how evolving nicotine regulations impact public health, community safety, and long-term regulatory outcomes, including the risks associated with illicit distribution networks and organized crime.
Understanding how illicit markets, enforcement gaps, and healthcare oversight interact is essential to developing balanced nicotine policies that support smoking cessation without contributing to the expansion of unregulated markets or increased youth access. Maintaining strong healthcare-based oversight helps ensure nicotine products remain connected to public health objectives rather than becoming broadly commercialized consumer products.
Canada is entering a critical period in nicotine policy. The decisions made now will determine whether nicotine pouches remain integrated within a healthcare-based smoking cessation framework or transition toward broad consumer retail normalization. Pharmacists are specifically trained to provide smoking cessation counselling, patient guidance, and support related to nicotine dependence, making healthcare settings the most appropriate environment for access to these products. Maintaining a high bar for sales through pharmacy-only access also creates a clearer and more enforceable regulatory framework, reducing ambiguity around compliance, oversight, and youth access protections.
OUR GOALS
Our Commitment to Healthcare-Based Nicotine Regulation
We are advocating for policies that preserve pharmacy oversight, strengthen enforcement against illicit sales, and reinforce smoking cessation objectives. Our advocacy efforts align with the need to:
1.
Protect and reinforce pharmacy-only nicotine pouch access within a healthcare-based smoking cessation framework.
2.
Strengthen enforcement against illicit and unregulated nicotine pouch sales in retail and online environments.
3.
Ensure pharmacists and healthcare professionals remain central participants in nicotine policy discussions.
4.
Support balanced, evidence-based nicotine regulation that prioritizes smoking cessation, youth protection, and professional oversight.
